Sonoma Pharma posts first EBITDA-positive quarter
Sonoma Pharmaceuticals Inc. (Nasdaq: SNOA) posted its first pre-tax net income in the third quarter of 2026.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Industrial technology company Trimble Inc. (Nasdaq: TRMB) saw its revenues and operating income drop in…
-
Sonoma Pharmaceuticals Inc. (Nasdaq: SNOA) reported record revenue and a lower net loss for the…
-
Sonoma Pharmaceuticals Inc. (Nasdaq: SNOA), a Boulder-based company that develops wound-care and dermatology products, has…
-
BizWest seeks input for its quarterly CEO Roundtable Executive Survey, focusing on expectations for the…
